Heiser LM, Sadanandam A, Kuo, W-L, Benz SC, Goldstein TC, Ng S, Gibb WJ, Want NJ, Ziyand S, Tong F, Bayani N, Hu Z, Billig JI, Dueregger A, Lewis S, Jakkula L, Korkola JE, Durinck S, Pepin F, Guan Y, Perdom E, Neuvial P, Bengsstom H, Wood KW, Smith PG, Vassilev L, Hennessy BT, Greshock JD, Bachman KE, Hardwicke MA, Park JW, Marton L, Wolf DW, Colisson EA. Neve RM, Mills GB. Speed TP, Feiler HS, Wooster RF, Haussler D, Stuart J, Gray JW, Spellman PT. Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2724-9. - Stand Up To Cancer

Blog

Posted September 17, 2019

Heiser LM, Sadanandam A, Kuo, W-L, Benz SC, Goldstein TC, Ng S, Gibb WJ, Want NJ, Ziyand S, Tong F, Bayani N, Hu Z, Billig JI, Dueregger A, Lewis S, Jakkula L, Korkola JE, Durinck S, Pepin F, Guan Y, Perdom E, Neuvial P, Bengsstom H, Wood KW, Smith PG, Vassilev L, Hennessy BT, Greshock JD, Bachman KE, Hardwicke MA, Park JW, Marton L, Wolf DW, Colisson EA. Neve RM, Mills GB. Speed TP, Feiler HS, Wooster RF, Haussler D, Stuart J, Gray JW, Spellman PT. Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2724-9.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.